Wedge Capital Management L L P NC lessened its holdings in Centene Corporation (NYSE:CNC – Free Report) by 34.7% during the 2nd quarter, Holdings Channel reports. The firm owned 487,090 shares of the company’s stock after selling 258,935 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Centene were worth $31,266,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. DV Equities LLC purchased a new stake in Centene in the 4th quarter valued at approximately $26,000. IFC & Insurance Marketing Inc. acquired a new position in shares of Centene in the fourth quarter valued at approximately $28,000. SBI Securities Co. Ltd. boosted its position in Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock worth $31,000 after acquiring an additional 406 shares during the last quarter. Bayban acquired a new position in Centene in the 4th quarter valued at $33,000. Finally, MV Capital Management Inc. acquired a new stake in shares of Centene during the fourth quarter worth $34,000. 93.63% of the stock is owned by hedge funds and other institutional investors.
Centene Stock Performance
NYSE CNC opened at $64.89 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 1.15. Centene Corporation has a 1-year low of $25.28 and a 1-year high of $69.36. The firm has a market capitalization of $32.06 billion, a P/E ratio of -6.22, a P/E/G ratio of 0.36 and a beta of 1.08. The business’s 50-day simple moving average is $64.67 and its 200-day simple moving average is $51.24.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on CNC shares. Robert W. Baird increased their target price on Centene from $46.00 to $66.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 29th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research note on Friday, July 17th. Zacks Research upgraded shares of Centene from a “hold” rating to a “strong-buy” rating in a report on Wednesday, July 29th. TD Cowen reaffirmed a “hold” rating and set a $65.00 price target (up from $47.00) on shares of Centene in a research report on Tuesday, July 14th. Finally, Argus raised shares of Centene from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $69.15.
Check Out Our Latest Research Report on CNC
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
